recurrence pterygium
Conditions
Interventions
(1) After Benoxil ophthalmic solution dropping lotion in the eyes anesthesia, perform washing eyes, disinfection. (2) After draping, put on ecarteur. (3) Add Xylocaine anesthesia to pterygium body
do. (11) Have top and bottom right and left move an eyeball and check follows and add suturation, if necessary( We confirm after consciousness returned in the case of a general anesthesia). (1) Is
Sponsors
Toyama University Hospital
Takaoka city hospital, Nagasaki University Hospital, Toho University Omori Medical Center, Matsue Red Cross Hospital, Kochi Medical School Hospital, University of Occupational and Environmental Health, Yamagata University Hospital, Akita University Hospital, University of Fukui Hospital, The University of Tokyo Hospital, Oita University Hospital, Hiroshima University Hospital, Shimane University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) age: The patients who relatively have good Patient 2) overall status of (at the agreement acquisition) 20 years old or older 3) The patients whom pathologic proliferative tissue invaded in recurrent pterygium across limbus. 4) The patients whom it is judged to be available for observation, the testing that conformed to a study enforcement plan and a survey
Exclusion criteria
Exclusion criteria: 1) onset pterygium patient or pseudopterygium patients. 2)The patients whom a doctor judged safely for 2) study period if it was difficult hospital visiting and to come home. 3)The patients who complicate eye infection with 3) activity. 4)The patients who plan the enforcement of eye operations for evaluation eyes effective during 4) study period in (we assume the agreement acquisition study initiation). 5)one eyes are the patients of enucleation eyes or evisceration eyes. 6)For the group medicine of the planned drug (dropping lotion in the eyes anesthetic agent, fluorescein) to use during 6) study period, it is the patients with a history of the drug allergy. 7)The patients (saying that, however, the subjects who do not receive the study drug are possible) who participated in other studies or clinical studies within six months. 8)The patients whom a doctor judged as an object of this study in testing at pregnancy or 9 childbearing patients) agreement acquisition that we might be pregnant or hoped for pregnancy during study period or did not use appropriate contraception for if inadequate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is the presence or absence of recurrence until 52 weeks after a surgical operation | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Decimal visual acuity tests (2) Ophthalmotonometry (3) An examination for slit lamp microscopy and anterior segment of eyeball OCT (4) Tensile speed of the pterygium tissue (measure it by anterior segment of eyeball OTC, and calculate it) (5) Funduscopy (6) A growth rate of the tissue | — |
Countries
Japan
Contacts
Public ContactAtsushi Hayashi
University of Toyama Department of Ophthalmology
Outcome results
None listed